We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Updated: 12/31/1969
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain
Updated: 12/31/1969
A Randomized Trial Comparing Coronary CT Angiography and Stress Echocardiography for Evaluation of Low-to-Intermediate Risk Emergency Department Chest Pain Patients
Status: Enrolling
Updated: 12/31/1969
Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain
Updated: 12/31/1969
A Randomized Trial Comparing Coronary CT Angiography and Stress Echocardiography for Evaluation of Low-to-Intermediate Risk Emergency Department Chest Pain Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings
Updated: 12/31/1969
Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings
Status: Enrolling
Updated: 12/31/1969
Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings
Updated: 12/31/1969
Correlation of Somatic Dysfunction With Gastrointestinal Endoscopic Findings
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ACAM2000® Myopericarditis Registry
Updated: 12/31/1969
ACAM2000® Myopericarditis Registry
Status: Enrolling
Updated: 12/31/1969
ACAM2000® Myopericarditis Registry
Updated: 12/31/1969
ACAM2000® Myopericarditis Registry
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Updated: 12/31/1969
North American Study of Epistaxis in HHT (NOSE)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Updated: 12/31/1969
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Status: Enrolling
Updated: 12/31/1969
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Updated: 12/31/1969
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Updated: 12/31/1969
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials